Maintenance strategies after first-line oxaliplatin plus fluoropyrimidine plus bevacizumab for patients with metastatic colorectal cancer (AIO 0207): a randomised, non-inferiority, open-label, phase 3 trial
| Autor: | Hegewisch-Becker, Susanna, Graeven, Ullrich, Lerchenmüller, Christian A, Killing, Birgitta, Depenbusch, Reinhard, Steffens, Claus-Christoph, Al-Batran, Salah-Eddin, Lange, Thoralf, Dietrich, Georg, Stoehlmacher, Jan, Tannapfel, Andrea, Reinacher-Schick, Anke, Quidde, Julia, Trarbach, Tanja, Hinke, Axel, Schmoll, Hans-Joachim, Arnold, Dirk |
|---|---|
| Zdroj: | In The Lancet Oncology October 2015 16(13):1355-1369 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|